Equity Overview
Price & Market Data
Price: $2.00
Daily Change: -$0.03 / 1.50%
Range: $2.00 - $2.00
Market Cap: $73,472,800
Volume: 500
Performance Metrics
1 Week: 2.78%
1 Month: 56.15%
3 Months: 7.41%
6 Months: -7.31%
1 Year: -21.01%
YTD: 9.73%
Company Details
Employees: 60
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.